PCVX - Vaxcyte, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg ยท closes rebased to 100 at each year's first session
Ticker Details
Vaxcyte, Inc.
IPO Date: July 12, 2020
Sector: Healthcare
Industry: Biotech
Market Cap: $9.67B
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.15 | 2.71%
Avg Daily Range (30 D): $1.17 | 1.90%
Avg Daily Range (90 D): $1.28 | 2.26%
Institutional Daily Volume
Avg Daily Volume: .71M
Avg Daily Volume (30 D): 2.13M
Avg Daily Volume (90 D): 1.38M
Trade Size
Avg Trade Size (Sh.): 60
Avg Trade Size (Sh.) (30 D): 68
Avg Trade Size (Sh.) (90 D): 62
Institutional Trades
Total Institutional Trades: 5,638
Avg Institutional Trade: $3.39M
Avg Institutional Trade (30 D): $3.31M
Avg Institutional Trade (90 D): $4.01M
Avg Institutional Trade Volume: .06M
Avg Institutional Trades (Per Day): 4
Market Closing Trades
Avg Closing Trade: $8.37M
Avg Closing Trade (30 D): $17.81M
Avg Closing Trade (90 D): $15.92M
Avg Closing Volume: 157.66K
 
News
Oct 7, 2026 @ 2:48 AM
Vaxcyte Announces Pricing of Concurrent Public Off...
Source: Na
Oct 6, 2026 @ 6:13 AM
Novavax (NVAX) Surges 20.1%: Is This an Indication...
Source: Na
Oct 5, 2026 @ 9:13 PM
Stock Market Today, Oct. 5: Tech Momentum Lifts Na...
Source: Emma Newbery
Sep 23, 2026 @ 12:37 PM
The Zacks Analyst Blog Highlights Kodiak Sciences,...
Source: Zacks Equity Research
Sep 8, 2026 @ 9:24 AM
Vaxcyte's CEO Parted With Shares for Taxes. Here's...
Source: Jonathan Ponciano
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-1.97 $-2.3
Diluted EPS $-1.97 $-2.3
Revenue $M $M
Gross Profit
Net Income / Loss $-284.3M $-320.62M
Operating Income / Loss $-302.78M $-345.85M
Cost of Revenue
Net Cash Flow $-77.65M $86.88M
PE Ratio